Junming Tong
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 6
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 1
- Chemokine receptors and signaling 1
-
- interferon and immune responses 2
- T-cell and B-cell Immunology 1
- Co-authors
- Andrea Paolo Bacigalupo (2 shared papers)Francesca Gualandi (2 shared papers)Domenico Occhini (2 shared papers)Teresa Lamparelli (2 shared papers)Francesco Frassoni (1 shared paper)G Sogno (1 shared paper)Elisabetta Tedone (1 shared paper)MT Van Lint (1 shared paper)
In The Last Decade
Junming Tong
9 papers receiving 434 citations
Junming Tong's Hit Papers
Peers
Comparison fields: 5 of 39
- Hematology 185
- Oncology 186
- Immunology 77
- Transplantation 5
- Aging 2
Countries citing papers authored by Junming Tong
This map shows the geographic impact of Junming Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junming Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junming Tong more than expected).
Fields of papers citing papers by Junming Tong
This network shows the impact of papers produced by Junming Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junming Tong. The network helps show where Junming Tong may publish in the future.
Co-authors
The 15 scholars most cited alongside Junming Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 200 | |
| 2 | FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy Hit paper breakdown → | 2024 | 167 |
| 3 | Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery Hit paper breakdown → | 2025 | 43 |
| 4 | 2023 | 12 | |
| 5 | 1991 | 8 | |
| 6 | 2025 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2025 | 4 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 0 |
About Junming Tong
Junming Tong is a scholar working on Oncology, Immunology, Hematology, Physiology and Genetics, having authored 10 papers that have together received 450 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), interferon and immune responses (2 papers), Adenosine and Purinergic Signaling (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), T-cell and B-cell Immunology (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Hematology (185 citations), Oncology (186 citations), Immunology (77 citations), Transplantation (5 citations) and Aging (2 citations). Junming Tong has collaborated with scholars based in Australia, Germany and Italy. Frequent co-authors include Andrea Paolo Bacigalupo, Francesca Gualandi, Domenico Occhini, Teresa Lamparelli, Francesco Frassoni, G Sogno, Elisabetta Tedone, MT Van Lint, A. M. Marmont and Maria Theresa Van Lint. Their work appears in journals such as Nature, Nature Communications, Cell Reports, Blood and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.